Aura Biosciences annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Aura Biosciences Depreciation & Amortization Growth & History (AURA)
Aura Biosciences's depreciation and amortization was $1.1M for fiscal 2025.
View full Aura Biosciences company overviewAura Biosciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.1M | −$94,000 | −7.69% |
| 2024 | 2024-12-31 | $1.2M | −$72,000 | −5.56% |
| 2023 | 2023-12-31 | $1.3M | $118,000 | +10.03% |
| 2022 | 2022-12-31 | $1.2M | $335,000 | +39.79% |
| 2021 | 2021-12-31 | $842,000 | $11,000 | +1.32% |
| 2020 | 2020-12-31 | $831,000 | — | — |
Aura Biosciences quarterly depreciation and amortization
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $300,000 | $0 | 0.00% |
| Q1 2026 | 2026-03-31 | $274,000 | −$17,000 | −5.84% |
| Q4 2025 | 2025-12-31 | $272,000 | — | — |
| Q3 2025 | 2025-09-30 | $300,000 | $0 | 0.00% |
| Q2 2025 | 2025-06-30 | $300,000 | $0 | 0.00% |
| Q1 2025 | 2025-03-31 | $291,000 | −$15,000 | −4.90% |
| Q3 2024 | 2024-09-30 | $300,000 | −$100,000 | −25.00% |
| Q2 2024 | 2024-06-30 | $300,000 | $0 | 0.00% |
| Q1 2024 | 2024-03-31 | $306,000 | −$22,000 | −6.71% |
| Q3 2023 | 2023-09-30 | $400,000 | $100,000 | +33.33% |
| Q2 2023 | 2023-06-30 | $300,000 | $0 | 0.00% |
| Q1 2023 | 2023-03-31 | $328,000 | $72,000 | +28.13% |
| Q3 2022 | 2022-09-30 | $300,000 | $100,000 | +50.00% |
| Q2 2022 | 2022-06-30 | $300,000 | $97,000 | +47.78% |
| Q1 2022 | 2022-03-31 | $256,000 | $63,000 | +32.64% |
| Q3 2021 | 2021-09-30 | $200,000 | $0 | 0.00% |
| Q2 2021 | 2021-06-30 | $203,000 | — | — |
| Q1 2021 | 2021-03-31 | $193,000 | — | — |
| Q3 2020 | 2020-09-30 | $200,000 | — | — |
Aura Biosciences depreciation and amortization trends
Over the last five fiscal years, Aura Biosciences's depreciation and amortization increased from $831,000 to $1.1M, a change of $298,000. The latest reported quarter, Q2 2026, shows $300,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aura Biosciences source filings ↗